In particular, pathological activation of MYC results in uncontrolled tumor growth (25), whereas strategies that inhibit MYC, either directly or indirectly, have been shown to cause a significant reduction in tumor size (4, 26, 27). The gene discussed is MYC; the disease is neoplasm.